PedAM
Pediatric Disease Annotations & Medicines
| Disease | hematopoietic stem cell transplantation |
| Phenotype | C0002874|aplastic anemia |
| Sentences | 9 |
| PubMedID- 22527354 | Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation. |
| PubMedID- 23724451 | Allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia. |
| PubMedID- 26121106 | Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia. |
| PubMedID- 24383400 | The treatment of pediatric severe aplastic anemia (saa) with allogeneic hematopoietic stem cell transplantation (allo-hsct), presents major challenges including the risks of graft failure, septic complications, and graft-versus-host disease (gvhd). |
| PubMedID- 23941840 | [progresses in studies on allogeneic hematopoietic stem cell transplantation in children with acquired severe aplastic anemia]. |
| PubMedID- 26125718 | Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia. |
| PubMedID- 22931664 | [clinical analysis of haploidentical or unrelated donor hematopoietic stem cell transplantation for patients with severe aplastic anemia]. |
| PubMedID- 26314454 | [efficacy analysis of allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia]. |
| PubMedID- 24488782 | Conditioning regimens consisting of reduced-dose cyclophosphamide (cy) and fludarabine (fdr) have been investigated for use in allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with aplastic anemia to reduce the toxicities associated with cy. |
Page: 1